We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$43B
AUM Growth
-$7.89B
(-16%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
8,577
New
1,058
Increased
2,469
Reduced
3,270
Closed
1,444
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$158M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 4 |
Boeing
BA
|
+$34.1M |
| 5 |
ARK Innovation ETF
ARKK
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$128M |
| 2 |
NVIDIA
NVDA
|
+$89M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$47.6M |
| 5 |
Biogen
BIIB
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.37% |
| 2 | Healthcare | 1.33% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Energy | 0.65% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4951
PUT
XWELL
XWEL
$8.53M
| $52.8K | ﹤0.01% |
7,280
-3,200
| -31% | -$35.5K |
|
4952
Standard BioTools
LAB
$308M
| $52.7K | ﹤0.01% |
45,084
+12,127
| +37% | +$14.9K |
|
4953
Enlivex Ltd
ENLV
$30.6M
| $52.6K | ﹤0.01% |
900
+868
| +2,713% | +$56K |
|
|
ROCC
4954
PUT
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $52.6K | ﹤0.01% |
1,300
+1,100
| +550% | +$43.6K |
|
|
DCPH
4955
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $52.4K | ﹤0.01% |
3,200
| – | – |
|
4956
PUT
Utz Brands
UTZ
$1.25B
| $52.3K | ﹤0.01% |
3,300
+2,200
| +200% | +$36.5K |
|
4957
Match Group
MTCH
$8.39B
| $52.2K | ﹤0.01% |
1,259
-8,557
| -87% | -$387K |
|
4958
CALL
Jackson Financial
JXN
$8.8B
| $52.2K | ﹤0.01% |
1,500
+300
| +25% | +$10.4K |
|
|
LILM
4959
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $52.2K | ﹤0.01% |
45,775
+31,572
| +222% | +$50K |
|
|
SPPI
4960
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $52K | ﹤0.01% |
141,207
+1,600
| +1% | +$675 |
|
4961
PUT
Cardlytics
CDLX
$22.6M
| $52K | ﹤0.01% |
+900
| New | +$55.6K |
|
4962
PUT
Archer Aviation
ACHR
$4.94B
| $52K | ﹤0.01% |
27,800
+6,500
| +31% | +$16K |
|
|
HCP
4963
PUT
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $51.9K | ﹤0.01% |
1,900
-4,700
| -71% | -$133K |
|
|
VLTA
4964
CALL
DELISTED
Volta Inc.
VLTA
| $51.8K | ﹤0.01% |
145,900
+4,900
| +3% | +$3.72K |
|
|
UXIN
4965
PUT
Uxin Ltd
UXIN
$262M
| $51.8K | ﹤0.01% |
1,800
+1,620
| +900% | +$58.2K |
|
|
VXRT
4966
DELISTED
Vaxart
VXRT
| $51.7K | ﹤0.01% |
53,852
-12,000
| -18% | -$17K |
|
4967
PUT
Main Street Capital
MAIN
$5.49B
| $51.7K | ﹤0.01% |
1,400
-3,500
| -71% | -$128K |
|
4968
CALL
Innoviva
INVA
$1.52B
| $51.7K | ﹤0.01% |
3,900
-5,800
| -60% | -$76.2K |
|
4969
PUT
Fox Class A
FOXA
$26B
| $51.6K | ﹤0.01% |
1,700
-2,100
| -55% | -$64.1K |
|
4970
NRX Pharmaceuticals
NRXP
$147M
| $51.6K | ﹤0.01% |
4,650
-6,708
| -59% | -$67.6K |
|
4971
Sphere Entertainment
SPHR
$6.16B
| $51.5K | ﹤0.01% |
+1,145
| New | +$51.9K |
|
4972
CALL
BigBear.ai
BBAI
$1.58B
| $51.4K | ﹤0.01% |
76,300
-320,100
| -81% | -$345K |
|
4973
CALL
CareDx
CDNA
$2.43B
| $51.3K | ﹤0.01% |
4,500
+4,300
| +2,150% | +$63.7K |
|
4974
Evolent Health
EVH
$467M
| $51.2K | ﹤0.01% |
1,822
+1,628
| +839% | +$46.7K |
|
|
NEUE
4975
DELISTED
NeueHealth
NEUE
| $51.1K | ﹤0.01% |
983
-719
| -42% | -$52.3K |
|
Similar funds
SCP
RIM
Group One Trading's Q4 2022 Portfolio in Review
As of Q4 2022, Group One Trading held 8,577 positions worth $43B, down 16% from $50.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Group One Trading withdrew a net $3.97B in Q4 2022, closing 1,444 positions and reducing 3,270 holdings. Its most notable exit was Biogen, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Cigna worth $165M.
- Group One Trading's largest Q4 2022 buy was Cigna: 497,989 shares worth $165M.
- Group One Trading added most to Microsoft in Q4 2022, an estimated $62.9M increase.
- Group One Trading's biggest Q4 2022 reduction was Tesla, cutting an estimated $128M.
- Group One Trading fully exited Biogen in Q4 2022, selling an estimated $30.6M.
- Group One Trading's ten largest holdings make up 22% of its $43B portfolio in Q4 2022.
- Group One Trading opened 1,058 new positions and closed 1,444 in Q4 2022.
- Group One Trading's portfolio value fell 16% quarter-over-quarter to $43B.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.